These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 9724117)

  • 1. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
    Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
    J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
    Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
    J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliosarcoma: a clinical study.
    Lutterbach J; Guttenberger R; Pagenstecher A
    Radiother Oncol; 2001 Oct; 61(1):57-64. PubMed ID: 11578729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
    Han SJ; Yang I; Otero JJ; Ahn BJ; Tihan T; McDermott MW; Berger MS; Chang SM; Parsa AT
    J Neurosurg; 2010 May; 112(5):990-6. PubMed ID: 19817543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma.
    Singh G; Mallick S; Sharma V; Joshi N; Purkait S; Jha P; Sharma MC; Suri V; Julka PK; Mahapatra AK; Singh M; Kale SS; Sarkar C
    Neuropathology; 2012 Oct; 32(5):534-42. PubMed ID: 22380407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliosarcoma: a rare variant of glioblastoma multiforme.
    Rizvi S; Asghar AH; Mehboob J
    J Pak Med Assoc; 2010 Sep; 60(9):773-5. PubMed ID: 21381591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma.
    Deb P; Sharma MC; Chander B; Mahapatra AK; Sarkar C
    Childs Nerv Syst; 2006 Mar; 22(3):314-9. PubMed ID: 16133270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics and treatment of rhabdoid glioblastoma.
    Babu R; Hatef J; McLendon RE; Cummings TJ; Sampson JH; Friedman AH; Adamson C
    J Neurosurg; 2013 Aug; 119(2):412-9. PubMed ID: 23641829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliosarcoma cerebri with a myxoid matrix of the sarcomatous component.
    Panayiotides JG; Arapantoni-Dadioti P; Lekka-Katsoulic J; Mariatos P; Delides GS
    Rom J Morphol Embryol; 1994; 40(1-2):45-50. PubMed ID: 7640376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy.
    Damodaran O; van Heerden J; Nowak AK; Bynevelt M; McDonald K; Marsh J; Lee G
    J Clin Neurosci; 2014 Mar; 21(3):478-81. PubMed ID: 24332268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.
    Pierscianek D; Ahmadipour Y; Michel A; Rauschenbach L; Darkwah Oppong M; Deuschl C; Kebir S; Wrede KH; Glas M; Stuschke M; Sure U; Jabbarli R
    Clin Neurol Neurosurg; 2021 Jan; 200():106348. PubMed ID: 33158630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An individual patient data meta-analysis on characteristics, treatments and outcomes of glioblastoma/ gliosarcoma patients with metastases outside of the central nervous system.
    Pietschmann S; von Bueren AO; Kerber MJ; Baumert BG; Kortmann RD; Müller K
    PLoS One; 2015; 10(4):e0121592. PubMed ID: 25860797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gliosarcoma: clinical experiences and additional information with MR spectroscopy.
    Buhl R; Stark AM; Hugo HH; Rohr A; Mehdorn HM
    Neurol Res; 2009 Oct; 31(8):873-7. PubMed ID: 19215667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
    Sreenan JJ; Prayson RA
    Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
    J Neurooncol; 1994; 21(2):177-85. PubMed ID: 7861194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative radiation therapy (IORT) for previously untreated malignant gliomas.
    Nemoto K; Ogawa Y; Matsushita H; Takeda K; Takai Y; Yamada S; Kumabe T
    BMC Cancer; 2002; 2():1. PubMed ID: 11818027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
    Simpson JR; Horton J; Scott C; Curran WJ; Rubin P; Fischbach J; Isaacson S; Rotman M; Asbell SO; Nelson JS
    Int J Radiat Oncol Biol Phys; 1993 May; 26(2):239-44. PubMed ID: 8387988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.